Glenda Margaret Halliday

Summary

Affiliation: Prince of Wales Medical Research Institute
Country: Australia

Publications

  1. doi request reprint The progression of pathology in Parkinson's disease
    Glenda Margaret Halliday
    Prince of Wales Medical Research Institute and University of New South Wales, Sydney, Australia
    Ann N Y Acad Sci 1184:188-95. 2010
  2. pmc Apolipoprotein-E forms dimers in human frontal cortex and hippocampus
    David A Elliott
    Prince of Wales Medical Research Institute, Randwick NSW 2031, Australia
    BMC Neurosci 11:23. 2010
  3. pmc Pedigree with frontotemporal lobar degeneration--motor neuron disease and Tar DNA binding protein-43 positive neuropathology: genetic linkage to chromosome 9
    Agnes A Luty
    Prince of Wales Medical Research Institute, Sydney, NSW, Australia
    BMC Neurol 8:32. 2008
  4. doi request reprint Clinicopathological aspects of motor parkinsonism
    Glenda Halliday
    Prince of Wales Medical Research Institute and the University of New South Wales, Sydney, Australia
    Parkinsonism Relat Disord 13:S208-10. 2007
  5. doi request reprint Thalamic changes in Parkinson's disease
    Glenda M Halliday
    Prince of Wales Medical Research Institute and University of New South Wales, Sydney, Australia
    Parkinsonism Relat Disord 15:S152-5. 2009
  6. doi request reprint No Lewy pathology in monkeys with over 10 years of severe MPTP Parkinsonism
    Glenda Halliday
    Prince of Wales Medical Research Institute and School of Medical Sciences, Faculty of Medicine University of New South Wales, Sydney, Australia
    Mov Disord 24:1519-23. 2009
  7. doi request reprint The progression of pathology in longitudinally followed patients with Parkinson's disease
    Glenda Halliday
    Prince of Wales Medical Research Institute and the University of New South Wales, Barker Street, Randwick, NSW, 2031, Australia
    Acta Neuropathol 115:409-15. 2008
  8. doi request reprint Clinical correlates of similar pathologies in parkinsonian syndromes
    Yun Ju Christine Song
    Neuroscience Research Australia and University of New South Wales, Randwick, New South Wales, Australia
    Mov Disord 26:499-506. 2011
  9. doi request reprint LRRK2 and parkin immunoreactivity in multiple system atrophy inclusions
    Yue Huang
    Prince of Wales Medical Research Institute, Barker Street, Randwick, NSW, 2031, Australia
    Acta Neuropathol 116:639-46. 2008
  10. doi request reprint Variations in the neuropathology of familial Alzheimer's disease
    Claire Shepherd
    Prince of Wales Medical Research Institute, Barker Street, Randwick, NSW, 2031, Australia
    Acta Neuropathol 118:37-52. 2009

Collaborators

Detail Information

Publications20

  1. doi request reprint The progression of pathology in Parkinson's disease
    Glenda Margaret Halliday
    Prince of Wales Medical Research Institute and University of New South Wales, Sydney, Australia
    Ann N Y Acad Sci 1184:188-95. 2010
    ..These data suggest that two age-related factors influence pathological progression in Parkinson's disease--the age at symptom onset and the degree and type of age-related Alzheimer-type pathology...
  2. pmc Apolipoprotein-E forms dimers in human frontal cortex and hippocampus
    David A Elliott
    Prince of Wales Medical Research Institute, Randwick NSW 2031, Australia
    BMC Neurosci 11:23. 2010
    ..Human frontal cortex and hippocampus from control and AD post-mortem samples were homogenised and analysed for apoE by western blotting under both reducing and non-reducing conditions...
  3. pmc Pedigree with frontotemporal lobar degeneration--motor neuron disease and Tar DNA binding protein-43 positive neuropathology: genetic linkage to chromosome 9
    Agnes A Luty
    Prince of Wales Medical Research Institute, Sydney, NSW, Australia
    BMC Neurol 8:32. 2008
    ..The objective in this study is to identify the genetic locus in a multi-generational Australian family with FTLD-MND...
  4. doi request reprint Clinicopathological aspects of motor parkinsonism
    Glenda Halliday
    Prince of Wales Medical Research Institute and the University of New South Wales, Sydney, Australia
    Parkinsonism Relat Disord 13:S208-10. 2007
    ....
  5. doi request reprint Thalamic changes in Parkinson's disease
    Glenda M Halliday
    Prince of Wales Medical Research Institute and University of New South Wales, Sydney, Australia
    Parkinsonism Relat Disord 15:S152-5. 2009
    ..Damage to these regions appears to impact on cognition, awareness and perception. These studies suggest that direct thalamic pathology contributes to the symptoms of Parkinson's disease...
  6. doi request reprint No Lewy pathology in monkeys with over 10 years of severe MPTP Parkinsonism
    Glenda Halliday
    Prince of Wales Medical Research Institute and School of Medical Sciences, Faculty of Medicine University of New South Wales, Sydney, Australia
    Mov Disord 24:1519-23. 2009
    ..This suggests that MPTP-induced oxidative stress and inflammation per se are not sufficient for Lewy body formation, or Lewy bodies are human specific...
  7. doi request reprint The progression of pathology in longitudinally followed patients with Parkinson's disease
    Glenda Halliday
    Prince of Wales Medical Research Institute and the University of New South Wales, Barker Street, Randwick, NSW, 2031, Australia
    Acta Neuropathol 115:409-15. 2008
    ..The data are also not consistent with a unitary concept of the pathogenesis of Lewy body disease...
  8. doi request reprint Clinical correlates of similar pathologies in parkinsonian syndromes
    Yun Ju Christine Song
    Neuroscience Research Australia and University of New South Wales, Randwick, New South Wales, Australia
    Mov Disord 26:499-506. 2011
    ....
  9. doi request reprint LRRK2 and parkin immunoreactivity in multiple system atrophy inclusions
    Yue Huang
    Prince of Wales Medical Research Institute, Barker Street, Randwick, NSW, 2031, Australia
    Acta Neuropathol 116:639-46. 2008
    ....
  10. doi request reprint Variations in the neuropathology of familial Alzheimer's disease
    Claire Shepherd
    Prince of Wales Medical Research Institute, Barker Street, Randwick, NSW, 2031, Australia
    Acta Neuropathol 118:37-52. 2009
    ..The mechanisms driving these pathological differences in AD are discussed...
  11. ncbi request reprint Partial lesion of thalamic ventral intermediate nucleus after chronic high-frequency stimulation
    Jasmine Henderson
    Department of Pharmacology, University of Sydney, NSW, Australia
    Mov Disord 19:709-11. 2004
    ..Post-mortem neuropathology (7 years postoperatively) revealed 60% cell loss within 0.5 mm of the electrode tip. Tremor improvement was attributable to chronic stimulation, not microthalamotomy...
  12. ncbi request reprint A functional polymorphism in the parkin gene promoter affects the age of onset of Parkinson's disease
    Greg Sutherland
    Prince of Wales Medical Research Institute, University of New South Wales, and Department of Neurology, Royal North Shore Hospital, Sydney, Australia
    Neurosci Lett 414:170-3. 2007
    ..6, 95% CI=1.41-245.3, p=0.03). We speculate that reduced expression of normal parkin protein may result in an early manifestation of PD symptoms...
  13. ncbi request reprint Genetic contributions to Parkinson's disease
    Yue Huang
    Prince of Wales Medical Research Institute and the University of New South Wales, Barker Street, Randwick, Sydney 2031, Australia
    Brain Res Brain Res Rev 46:44-70. 2004
    ..The identification of multiple genes predisposing to Parkinson's disease will assist in determining the cellular pathway/s leading to the neurodegeneration observed in this disease...
  14. ncbi request reprint Beta-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes
    Della C David
    Alzheimer s and Parkinson s Disease Laboratory, Brain and Mind Research Institute, University of Sydney, Camperdown, NSW, Australia
    Proteomics 6:6566-77. 2006
    ..These data highlight these processes as potentially important initiators in the Abeta42-mediated pathogenic cascade in AD and further support the role of unfolded proteins in the course of AD...
  15. ncbi request reprint Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity?
    Dag Aarsland
    Psychiatric Clinic, Rogaland Central Hospital, PO Box 1163, Hillevaag, 4095 Stavanger, Norway
    J Geriatr Psychiatry Neurol 17:137-45. 2004
    ....
  16. ncbi request reprint Clarifying Lewy-body parkinsonism with visual hallucinations
    Glenda Halliday
    Lancet Neurol 4:588-9. 2005
  17. ncbi request reprint The etiopathogenesis of Parkinson disease and suggestions for future research. Part II
    Irene Litvan
    University of Louisville School of Medicine, Louisville, Kentucky 40202, USA
    J Neuropathol Exp Neurol 66:329-36. 2007
    ..Topics reviewed in Part II are genetics, animal models, and oxidative stress...
  18. doi request reprint Clarifying the pathological progression of Parkinson's disease
    Glenda Halliday
    Acta Neuropathol 115:377-8. 2008
  19. ncbi request reprint The etiopathogenesis of Parkinson disease and suggestions for future research. Part I
    Irene Litvan
    University of Louisville School of Medicine, Louisville, Kentucky 40202, USA
    J Neuropathol Exp Neurol 66:251-7. 2007
  20. ncbi request reprint Dementia with Lewy bodies
    Ian McKeith
    Institute for Ageing and Health, University of Newcastle, Newcastle upon Tyne, UK
    Lancet Neurol 3:19-28. 2004
    ..Clear guidance on the management of DLB is urgently needed. Virtually unrecognised 20 years ago, DLB could within this decade be one of the most treatable neurodegenerative disorders of late life...